<DOC>
	<DOCNO>NCT01144416</DOCNO>
	<brief_summary>The purpose study show single injection SCH 900962/MK-8962 non-inferior daily injection recombinant follicle-stimulating hormone ( recFSH ) first week ovarian stimulation term number vital pregnancy ( ie , presence least one fetus heart activity assess ultrasound least 35 day embryo transfer ) woman age 35 42 year undergo control ovarian stimulation ( COS ) prior vitro fertilization ( IVF ) intracytoplasmic sperm injection ( ICSI ) .</brief_summary>
	<brief_title>Efficacy Safety Study Single Injection SCH 900962 Versus Daily recFSH Injections Women Undergoing Controlled Ovarian Stimulation ( Study P06029 )</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Willing able provide write informed consent trial P06029 well FrozenThawed Embryo Transfer ( FTET ) followup trial P06031 , pharmacogenetic analysis ( applicable ) . Female &gt; =35 &lt; =42 year age indication COS IVF/ICSI . Body weight ≥50.0 kg , body mass index ( BMI ) &gt; =18.0 &lt; =32.0 kg/m2 . Regular spontaneous menstrual cycle variation outside 2435 day . Ejaculatory sperm must available ( donate and/or cryopreserved sperm allow ) . Results clinical laboratory test , cervical smear , physical examination within normal limit clinically acceptable investigator . Adhere trial schedule . A recent history of/or current endocrine abnormality . A history ovarian hyperresponse ovarian hyperstimulation syndrome ( OHSS ) . A history of/or current polycystic ovary syndrome . More 20 basal antral follicle &lt; 11 mm ( ovary combine ) early follicular phase . Less 2 ovary ovarian abnormality . Unilateral bilateral hydrosalpinx . Intrauterine fibroid ≥5 cm clinically relevant pathology , could impair embryo implantation pregnancy continuation . More three unsuccessful COS cycle IVF/ICSI since last establish ongoing pregnancy ( applicable ) . A history non low ovarian response FSH/human menopausal gonadotropin ( hMG ) treatment . A history recurrent miscarriage . FSH &gt; 15.0 IU/L luteinizing hormone ( LH ) &gt; 12.0 IU/L early follicular phase . Positive human immunodeficiency virus ( HIV ) Hepatitis B. Contraindications use gonadotropin gonadotropin release hormone ( GnRH ) antagonists . A recent history of/or current epilepsy , thrombophilia , diabetes , cardiovascular , gastrointestinal , hepatic , renal pulmonary autoimmune disease require regular treatment . Smoking recently stop smoking ( ie , within last 3 month prior sign informed consent ) . A recent history presence alcohol drug abuse . The participant sperm donor know gene defect , genetic abnormality , abnormal karyotyping , relevant current indication health offspring . Prior concomitant medication disallow protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Reproductive Techniques , Assisted</keyword>
	<keyword>Follicle Stimulating Hormone , Human</keyword>
	<keyword>Fertilization In Vitro</keyword>
</DOC>